跳至主要内容
临床试验/NCT02736383
NCT02736383已完成不适用

Effectiveness of Tranexamic Acid (TXA) in Reducing Blood Loss in Hip Fracture Surgery

Spectrum Health Hospitals0 个研究点目标入组 142 人开始时间: 2016年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
142
主要终点
Blood Transfusion Rate

研究概览

简要总结

To determine if TXA utilization is effective at reducing transfusion rates in elderly patients undergoing surgery for treatment of a hip fractures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute, isolated, unilateral femoral neck, intertrochanteric, and per trochanteric hip fractures confirmed by anteroposterior/lateral hip radiographs, computed tomography, or magnetic resonance imaging.
  • Age 65 and older
  • Low energy mechanism of injury
  • Hip fracture fixation performed within 48 hours
  • English speaking
  • Anticipated medical optimization for operative fixation
  • No other major trauma

排除标准

  • Retained hardware around the affected hip
  • Infection around the affected hip
  • Transfer patients with a length of stay > 24 hours at the transferring hospital
  • Diagnosis of deficient natural anticoagulation
  • Known congenital thrombophilia (Deficiency of Protein C, S, Antithrombin)
  • Known allergy to TXA
  • Patients undergoing percutaneous pinning of the hip fracture

结局指标

主要结局

Blood Transfusion Rate

时间窗: 6 weeks

Blood transfusion rates during the patients hospital stay will be assessed.

次要结局

  • Hospital Length of stay(6 weeks)
  • Post operative complications(6 weeks)
  • Hospitalization costs(6 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验